Literature DB >> 91613

Human alpha-fetoprotein. Fluorescence studies on binding and proximity relationships for fatty acids and bilirubin.

C B Berde, M Nagai, H F Deutsch.   

Abstract

The binding of bilirubin and the polyene fatty acids cis-parinaric acid and cis-eleostearic acid to human alpha-fetoprotein was studied using fluorescence quenching and fluorescence enhancement techniques. alpha-Fetoprotein has three fatty acid binding sites of decreasing affinity (association constants 2.1 x 10(7) M-1 9.1 X 10(5) M-1, and 1.4 x 10(5) M-1) and one relatively strong and one relatively weak bilirubin binding site (association constants 1.1 x 10(7) M-1 and 1.8 x 10(5) M-1). These association constants are slightly weaker than the corresponding association constants for binding to human albumin. Competition experiments failed to show preferential binding of polyunsaturated fatty acids. Fluorescence quenching was used to determine 11 ligand-ligand and ligand-tryptophanyl residue distances. Each of these 11 calculated distances (ranging from 19 A to 32 A) was within 5 A of the corresponding distances measured previously for human albumin (Berde, C.B., Hudson, B.S., Simoni, R.D., and Sklar, L.A. 1979, J. Biol. Chem. 254, 391-400). Thus, in addition to previously described sequence homology, immunologic cross-reactivity, and other similarities, human albumin and human alpha-fetoprotein have functional and geometric homologies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91613

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The fatty acid analogue 11-(dansylamino)undecanoic acid is a fluorescent probe for the bilirubin-binding sites of albumin and not for the high-affinity fatty acid-binding sites.

Authors:  D C Wilton
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

2.  The refolding of different alpha-fetoprotein variants.

Authors:  Susanna S J Leong; Anton P J Middelberg
Journal:  Protein Sci       Date:  2006-08-01       Impact factor: 6.725

Review 3.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

4.  Localization of the estrogen-binding site of alpha-fetoprotein in the chimeric human-rat proteins.

Authors:  S Nishi; H Matsue; H Yoshida; R Yamaoto; M Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  High affinity of alpha-foetoprotein for arachidonate and other fatty acids.

Authors:  R N Carlsson; T Estes; J Degroot; J T Holden; E Ruoslahti
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

6.  Drug-binding properties of human alpha-foetoprotein.

Authors:  K Hirano; Y Watanabe; T Adachi; Y Ito; M Sugiura
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

7.  Secretion and glycosylation of alpha-foetoprotein by the mouse yolk sac.

Authors:  R G Janzen; T Tamaoki
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

Review 8.  The partition of cis-parinaric acid and trans-parinaric acid among aqueous, fluid lipid, and solid lipid phases.

Authors:  L A Sklar
Journal:  Mol Cell Biochem       Date:  1980-11-20       Impact factor: 3.396

Review 9.  Alpha-fetoprotein: a renaissance.

Authors:  A A Terentiev; N T Moldogazieva
Journal:  Tumour Biol       Date:  2013-06-14

10.  Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.

Authors:  F Hervé; K Rajkowski; M T Martin; P Dessen; N Cittanova
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.